You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 1, January 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Millennium Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Hey Mrs Robinson, It's Therapeutics!

Steven P. Ringel, MD

Arch Neurol. 2000;57:56.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the movie The Graduate from the 1960s, Benjamin Braddock (played by Dustin Hoffman) is advised to pursue a promising career in plastics. For those of us who practice neurology today and wonder about innovations in the next millennium, my vote is for therapeutics. Although neurology was once considered a diagnostic specialty without effective treatments, the staggering number of therapeutic options available today has definitely changed that perception. Consider the numerous drugs available for effective management of migraine, epilepsy, Parkinson disease and other movement disorders, myasthenia gravis, and chronic pain syndromes, to mention only a few. The genetic revolution has increased the understanding of the panoply of genetic defects that can produce neurological dysfunction. It also has provided the tools to bioengineer pharmaceuticals that lessen relapses in multiple sclerosis, dissolve a thrombus occluding a cerebral artery, regenerate a damaged peripheral nerve in patients with diabetes, and . . . [Full Text of this Article]

From the Department of Neurology, University of Colorado Health Science Center, Denver.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.